Corona Prandi B, P Rosim M, Ogata Pedro G, Papadimitropoulos M. Cost per number needed to treat and treatment cost of baricitinib versus adalimumab on rheumatoid arthritis treatment in the brazilian private healthcare system . JAFF [Internet]. 1º de fevereiro de 2023 [citado 26º de julho de 2026];4(s.1). Disponível em: https://www.ojs.jaff.org.br/ojs/index.php/jaff/article/view/554